Literature DB >> 9355426

Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure.

M Cunningham1.   

Abstract

Ecstasy (MDMA) is widely used within the dance scene of the 1990s. In this article the growing trend of ecstasy usage among teenagers is considered, in particular, one of its potentially devastating side-effects, rhabdomyolysis. From consideration of the pathophysiology of rhabdomyolysis and its role in the development of acute renal failure, it becomes apparent that preventative measures and prompt treatment can prevent patients developing acute renal failure as a consequence of rhabdomyolysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355426     DOI: 10.1016/s0964-3397(97)80056-0

Source DB:  PubMed          Journal:  Intensive Crit Care Nurs        ISSN: 0964-3397            Impact factor:   3.072


  5 in total

Review 1.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

Review 2.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

3.  Rhabdomyolysis related to acute recreational drug toxicity-A Euro-DEN study.

Authors:  Wojciech Waldman; Piotr M Kabata; Alison M Dines; David M Wood; Christopher Yates; Fridtjof Heyerdahl; Knut Erik Hovda; Isabelle Giraudon; Paul I Dargan; Jacek Sein Anand
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

4.  Short-Term High-Dose Steroid Therapy in a Case of Rhabdomyolysis Refractory to Intravenous Fluids.

Authors:  Fnu Zarlasht; Mashal Salehi; Alamgir Sattar; Mohammad Abu-Hishmeh; Muzammil Khan
Journal:  Am J Case Rep       Date:  2017-10-17

Review 5.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.